Foletta Mark G's Form 4 filing
Dexcom Inc (DXCM) · filed Aug 18, 2025
- Accession no.
- 0001093557-25-000245
- Filed
- Aug 18, 2025
- Trade date
- Aug 15, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $222.9K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Foletta Mark GCIK 0001236389 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Common Stock | SSaleDisposed | −2,555 | $81.02 | −$207,006.1 | 51,316 | Indirect | |
| Aug 15, 2025 | Common Stock | SSaleDisposed | −195 | $81.54 | −$15,900.3 | 51,121 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.